• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载药纳米脂质体包裹吉西他滨并修饰精氨酸-甘氨酸-天冬氨酸提高乳腺癌抑制活性。

Encapsulation of gemcitabine in RGD-modified nanoliposomes improves breast cancer inhibitory activity.

机构信息

Department of Oncology, Suzhou Ninth People's Hospital, Suzhou, China.

出版信息

Pharm Dev Technol. 2020 Jun;25(5):640-648. doi: 10.1080/10837450.2020.1727920. Epub 2020 Feb 26.

DOI:10.1080/10837450.2020.1727920
PMID:32028816
Abstract

In this study, RGD coated GEM liposomes were prepared by the emulsification-solvent evaporation method. The and characterizations were done to evaluate the feasibility of application. The mean particle size of the prepared liposomes was found to be 165.6 ± 15.7 nm. The entrapment efficiency and drug loading of the formulation were 82.4% ± 7.2% and 10.1% ± 1.4%, respectively. The liposomes were negatively charged with a zeta potential of -25.8 mV. The surface morphology of RGD-GEM liposomes was spherical and smooth. After three months of storage at different conditions, lyophilized liposomes appeared to be stable since they showed no collapse or contraction. The Weibull model was the most appropriate kinetic model for RGD-GEM liposomes, showing that the release of GEM from the liposomes was in the manners of both dissolution and diffusion. , the additive cytotoxicity of RGD-GEM-LPs in our study was caused by the presence of RGD which is more effective in the treatment of breast cancer devoid of toxicity to normal cells. Liposomes could also significantly extend the role of GEM and showed higher bioavailability than solution.

摘要

在这项研究中,通过乳化-溶剂蒸发法制备了 RGD 涂层 GEM 脂质体。对其进行了 和 特性评估,以验证其应用的可行性。结果发现,所制备的脂质体的平均粒径为 165.6±15.7nm。包封率和载药量分别为 82.4%±7.2%和 10.1%±1.4%。脂质体带负电荷,zeta 电位为-25.8mV。RGD-GEM 脂质体的表面形态呈球形且光滑。在不同条件下储存三个月后,冻干脂质体似乎很稳定,因为它们没有塌陷或收缩。Weibull 模型是最适合 RGD-GEM 脂质体的动力学模型,表明 GEM 从脂质体中的释放方式既有溶解也有扩散。此外,本研究中 RGD-GEM-LPs 的附加细胞毒性是由于存在 RGD 所致,RGD 对乳腺癌的治疗更有效,而对正常细胞没有毒性。脂质体还可以显著延长 GEM 的作用时间,并显示出比溶液更高的生物利用度。

相似文献

1
Encapsulation of gemcitabine in RGD-modified nanoliposomes improves breast cancer inhibitory activity.载药纳米脂质体包裹吉西他滨并修饰精氨酸-甘氨酸-天冬氨酸提高乳腺癌抑制活性。
Pharm Dev Technol. 2020 Jun;25(5):640-648. doi: 10.1080/10837450.2020.1727920. Epub 2020 Feb 26.
2
Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies.载吉西他滨的RGD修饰脂质体用于卵巢癌:制备、表征及药效学研究
Drug Des Devel Ther. 2019 Sep 17;13:3281-3290. doi: 10.2147/DDDT.S211168. eCollection 2019.
3
A Liposomal Gemcitabine, FF-10832, Improves Plasma Stability, Tumor Targeting, and Antitumor Efficacy of Gemcitabine in Pancreatic Cancer Xenograft Models.一种脂质体吉西他滨(FF-10832)可提高胰腺癌异种移植模型中吉西他滨的血浆稳定性、肿瘤靶向性和抗肿瘤疗效。
Pharm Res. 2021 Jun;38(6):1093-1106. doi: 10.1007/s11095-021-03045-5. Epub 2021 May 7.
4
Gemcitabine-Phospholipid Complex Loaded Lipid Nanoparticles for Improving Drug Loading, Stability, and Efficacy against Pancreatic Cancer.载吉西他滨磷脂复合物的脂质纳米粒提高药物载药量、稳定性及对胰腺癌疗效的研究
Mol Pharm. 2024 Jun 3;21(6):2699-2712. doi: 10.1021/acs.molpharmaceut.3c00983. Epub 2024 May 15.
5
Enhanced pH-Responsiveness, Cellular Trafficking, Cytotoxicity and Long-circulation of PEGylated Liposomes with Post-insertion Technique Using Gemcitabine as a Model Drug.以吉西他滨为模型药物,采用后插入技术的聚乙二醇化脂质体增强pH响应性、细胞转运、细胞毒性及长循环性能
Pharm Res. 2015 Jul;32(7):2428-38. doi: 10.1007/s11095-015-1635-0. Epub 2015 Feb 6.
6
Development of high-content gemcitabine PEGylated liposomes and their cytotoxicity on drug-resistant pancreatic tumour cells.高含量吉西他滨聚乙二醇化脂质体的研制及其对耐药胰腺肿瘤细胞的细胞毒性
Pharm Res. 2014 Oct;31(10):2583-92. doi: 10.1007/s11095-014-1353-z. Epub 2014 Mar 18.
7
Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells.包裹吉西他滨的透明质酸共轭脂质体用于乳腺癌干细胞
Int J Nanomedicine. 2016 Apr 5;11:1413-25. doi: 10.2147/IJN.S95850. eCollection 2016.
8
Development of Gemcitabine Loaded PLGA/Lecithin Nanoparticles for Non-Small Cell Lung Cancer Therapy.载盐酸吉西他滨 PLGA/大豆卵磷脂纳米粒的制备及其对非小细胞肺癌的治疗作用。
Curr Drug Deliv. 2020;17(7):622-628. doi: 10.2174/1567201817666200512094145.
9
Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)-poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy.甲氧基聚(乙二醇)-聚(丙交酯-乙交酯)-多肽纳米粒共递送紫杉醇和吉西他滨用于有效的乳腺癌治疗
Anticancer Drugs. 2018 Aug;29(7):637-645. doi: 10.1097/CAD.0000000000000631.
10
Antitumor activity of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs): In vitro and in vivo.盐酸吉西他滨载药脂质聚合物杂化纳米粒(LPHNs)的抗肿瘤活性:体内外研究。
Int J Pharm. 2020 Apr 30;580:119246. doi: 10.1016/j.ijpharm.2020.119246. Epub 2020 Mar 20.

引用本文的文献

1
A Comprehensive Review on Novel Lipid-Based Nano Drug Delivery.新型脂质纳米药物递送系统综述
Adv Pharm Bull. 2024 Mar;14(1):34-47. doi: 10.34172/apb.2024.012. Epub 2023 Oct 14.
2
TPGS Decorated Liposomes as Multifunctional Nano-Delivery Systems.TPGS 修饰的脂质体作为多功能纳米递药系统。
Pharm Res. 2023 Jan;40(1):245-263. doi: 10.1007/s11095-022-03424-6. Epub 2022 Nov 14.
3
A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer Therapy.载 RGD-HSA 的 GEM/CUR 纳米粒新型递药系统用于胰腺癌治疗。
Drug Des Devel Ther. 2022 Jul 26;16:2395-2406. doi: 10.2147/DDDT.S366558. eCollection 2022.
4
Recent Advances in Lipid-Based Nanosystems for Gemcitabine and Gemcitabine-Combination Therapy.用于吉西他滨及吉西他滨联合治疗的脂质纳米系统的最新进展
Nanomaterials (Basel). 2021 Feb 27;11(3):597. doi: 10.3390/nano11030597.
5
Gemcitabine Peptide-Based Conjugates and Their Application in Targeted Tumor Therapy.基于吉西他滨的肽类偶联物及其在靶向肿瘤治疗中的应用。
Molecules. 2021 Jan 12;26(2):364. doi: 10.3390/molecules26020364.